BIO.US Bio-Rad Laboratories Inc

Healthcare Life Sciences Tools & Services USA Stocks
451.28 USD
Close of Nov 13, 2026
236.73 396.23
Market cap
USD 9.85B
P/E
9.7x
P/B
1.31x
ROE
5.3%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.

Is BIO.US undervalued?

Graham number
Price451.28
Graham value599.39
Discount24.7%

BIO.US trades 24.7% below its Graham number.

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Bio-Rad Laboratories Inc fundamental analysis

No fundamental analysis for Bio-Rad Laboratories Inc yet.

Bio-Rad Laboratories Inc stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Bio-Rad Laboratories Inc

Bio-Rad Laboratories, Inc. develops, manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, Latin America, and internationally. It operates through two segments, Life Science and Clinical Diagnostics. The Life Science segment develops, manufactures, and markets instruments, systems, reagents, and consumables to separate, purify, characterize, and quantify biological materials, including cells, proteins…

Full company profile